Capital Markets: Equity (International Firms)
China
5 years ranked
Capital Markets: Equity (International Firms)
China
5 years ranked
Provided by Edwin Kwok & Co
Edwin Kwokis a leading Corporate and Capital Markets lawyer with extensive experience advising major investment banks, healthcare and TMT issuers, life science and biotech firms, Chinese state-owned enterprises, real estate and property management companies on their initial public offerings, cross-border acquisitions, public takeovers, privatizations, spin-offs, corporate compliance, SFC’s licensing and follow-on offerings of equity and debt securities.
Edwin has extensive experience includes advising on some of the most significant capital markets and mergers and acquisitions transactions in the Asia region. He has advised on numerous securities offerings on the Hong Kong Stock Exchange, public takeovers and listing rules regulated notifiable transactions, some of which were highly complex involving complicated cross border implications. He has represented a number of biotech and healthcare companies in their listings on the Main Board of the Hong Kong Stock Exchange, including RemeGen, Akeso, Brii Biosciences, Pharmaron Beijing, Peijia Medical, Honliv Healthcare Management, Cryofocus Medtech, Jenscare Scientific, Acotec Scientific, Shanghai Bio-heart, Shanghai HeartCare Medical, KeyMed Biosciences, Jacobio Pharmaceuticals, Hygeia Health, and Simcere Pharmaceutical. He is also deeply experienced with privatizations and takeovers of Hong Kong listed companies.
Before founding Edwin Kwok and Co, Edwin was a partner at O’Melveny & Myers and Paul Hastings. He has led in building and positioning O’Melveny & Myers as the market leader for life science and biotech capital markets transactions following the adoption by the Hong Kong Stock Exchange of Chapter 18A into its listing rules.
Freshfields Bruckhuas Deringer (2004-2010)
Paul Hastings (2010-2016)
O'Melveny & Myers (2016-2024)
Edwin Kwok & Co (2024 - )
University of Hong Kong
LLB
1999 - 2002
University of Hong Kong
PCLL
2002 - 2003
Cambridge University
LLM
2003 - 2004
The A-List: Growth Drivers
China Business Law Journal
2026
A-List of China’s 100 Elite Foreign Lawyers
China Business Law Journal
2024
Highly regarded (M&A)
IFLR
2023
Capital Markets (Equity)
Legal 500
2023
Hong Kong and England & Wales
Provided by Chambers
Edwin Kwok handles a range of ECM mandates for both issuers and underwriters on listings in Mainland China and Hong Kong.
Provided by Chambers
He's very dedicated as the founding partner of the firm. I appreciate that Edwin is efficient and allocates resources effectively.
Edwin is very well-known in the industry and has rich experience.
Chambers is the leading data and intelligence partner for the legal sector.